SMS Pharmaceuticals has successfully completed its fifth US Food and Drug Administration (US FDA) inspection for its manufacturing facility Unit-II located at Plot No.24 & 24B and 36 & 37, S V Co-operative Industrial Estate, Bachupally, Ranga Reddy District, Hyderabad in state of Telangana. There were no ‘Form 483’ observations issued during the inspection.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. They are the single largest producer of anti-ulcer products.
